Accessibility Menu
USANA Health Sciences Stock Quote

USANA Health Sciences (NYSE: USNA)

$21.02
(1.6%)
+0.34
Price as of October 21, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$21.03
Daily Change
(1.6%) +$0.34
Day's Range
$20.54 - $21.39
Previous Close
$21.03
Open
$20.72
Beta
0.72
Volume
202,806
Average Volume
151,921
Market Cap
377.9M
Market Cap / Employee
$20.68M
52wk Range
$19.88 - $41.84
Revenue
-
Gross Margin
0.77%
Dividend Yield
N/A
EPS
$0.89
CAPs Rating
-
Industry
Personal Products

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

USANA Health Sciences Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
USNA-40%-74.96%-24.19%+3,294%
S&P+14.84%+96.04%+14.41%+1,110%

USANA Health Sciences Company Info

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$214.00M6.9%
Gross Profit$177.92M5.5%
Gross Margin75.44%-3.8%
Market Cap$503.39M-30.3%
Market Cap / Employee$0.30M0.0%
Employees1.7K-5.6%
Net Income-$6.50M-161.3%
EBITDA$26.32M11.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$151.34M-54.5%
Inventory83.334.7%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.00M0.0%
Short Term Debt$0.00M0.0%

Ratios

Q2 2025YOY Change
Return On Assets5.00%-3.9%
Return On Invested Capital18.33%-4.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$7.19M35.2%
Operating Free Cash Flow$12.22M52.9%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings16.3015.2117.2732.01138.71%
Price to Book1.280.971.080.95-32.83%
Price to Sales0.800.610.640.57-31.91%
Price to Tangible Book Value1.412.182.412.0633.18%
Price to Free Cash Flow TTM11.0313.3910.7911.32-22.60%
Enterprise Value to EBITDA16.9542.1116.5018.24-19.62%
Free Cash Flow Yield9.1%7.5%9.3%8.8%29.20%
Return on Equity10.8%7.8%6.8%6.5%-41.75%
Total Debt$0.00M$39.20M$23.00M$0.00M-

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.